当前位置:首页 - 行情中心 - 甘李药业(603087) - 财务分析 - 现金流量表

甘李药业

(603087)

  

流通市值:412.70亿  总市值:442.05亿
流通股本:5.58亿   总股本:5.98亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,844,216,752.72908,976,184.93,288,200,661.22,405,077,571.1
  收到的税费返还44,572,971.940,666,316.1867,514,079.8167,547,714.01
  收到其他与经营活动有关的现金70,666,424.6467,079,616.1332,558,036.649,914,697.24
  经营活动现金流入小计1,959,456,149.261,016,722,117.213,388,272,777.652,482,539,982.35
  购买商品、接受劳务支付的现金528,571,696.5261,817,120.26877,788,113.15641,934,128.62
  支付给职工以及为职工支付的现金529,804,354.61244,825,723.94868,551,344.92639,530,019.39
  支付的各项税费187,711,333.93103,046,569.52167,704,019.5981,065,798.62
  支付其他与经营活动有关的现金464,818,522.13248,286,436.72936,919,576.69654,669,741.87
  经营活动现金流出小计1,710,905,907.17857,975,850.442,850,963,054.352,017,199,688.5
  经营活动产生的现金流量净额248,550,242.09158,746,266.77537,309,723.3465,340,293.85
二、投资活动产生的现金流量:
  收回投资收到的现金3,100,430,2702,022,569,7708,766,979,387.427,070,151,578.75
  取得投资收益收到的现金55,644,592.6834,674,396.0588,224,339.1421,503,965.64
  处置固定资产、无形资产和其他长期资产收回的现金净额18,056819,494.19--
  收到的其他与投资活动有关的现金--2,604,019.812,484,645.75
  投资活动现金流入小计3,156,092,918.682,058,063,660.248,857,807,746.377,094,140,190.14
  购建固定资产、无形资产和其他长期资产支付的现金366,970,304.43157,871,020.42440,801,383.9294,762,231.72
  投资支付的现金2,259,069,011.671,872,948,242.748,679,034,759.97,279,256,512.68
  投资活动现金流出小计2,626,039,316.12,030,819,263.169,119,836,143.87,574,018,744.4
  投资活动产生的现金流量净额530,053,602.5827,244,397.08-262,028,397.43-479,878,554.26
三、筹资活动产生的现金流量:
  吸收投资收到的现金--139,321,600139,321,600
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--139,321,600139,321,600
  分配股利、利润或偿付利息支付的现金597,525,269-420,547,253118,247,550
  支付其他与筹资活动有关的现金135,819,147.0775,214,479.719,488,13019,159,981.31
  筹资活动现金流出小计733,344,416.0775,214,479.7440,035,383137,407,531.31
  筹资活动产生的现金流量净额-733,344,416.07-75,214,479.7-300,713,7831,914,068.69
四、汇率变动对现金及现金等价物的影响3,302,350.071,466,877.94-951,386.7-1,572,201.8
五、现金及现金等价物净增加额48,561,778.67112,243,062.09-26,383,843.83-14,196,393.52
  加:期初现金及现金等价物余额260,055,136.76260,055,136.76286,438,980.59286,438,980.59
  期末现金及现金等价物余额308,616,915.43372,298,198.85260,055,136.76272,242,587.07
补充资料:
  净利润603,680,572.48-614,663,800.7-
  资产减值准备-18,215.12-15,656,632.99-
  固定资产和投资性房地产折旧132,680,148.88-240,956,510.52-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧132,680,148.88-240,956,510.52-
  无形资产摊销9,269,121.11-15,073,711.59-
  长期待摊费用摊销884,377.08-1,768,304.77-
  处置固定资产、无形资产和其他长期资产的损失---1,866,209.36-
  固定资产报废损失107,351.01-711,631.62-
  公允价值变动损失-64,965,330.59--156,612,377.87-
  财务费用-48,205,553.83--90,764,224.8-
  投资损失-7,356,114.57--61,249,137.11-
  递延所得税-20,390,658.37--28,565,809.8-
  其中:递延所得税资产减少-13,330,978.7--40,676,561.32-
    递延所得税负债增加-7,059,679.67-12,110,751.52-
  存货的减少-121,169,652.02--203,039,601.32-
  经营性应收项目的减少-506,000,735.9-132,153,044.31-
  经营性应付项目的增加229,370,078.69--37,493,974.76-
  其他38,824,093.87-112,851,523.53-
  不涉及现金收支的投资和筹资活动金额其他项目5,081,623.23-19,394,709.27-
  现金的期末余额308,616,915.43-260,055,136.76-
  减:现金的期初余额260,055,136.76-286,438,980.59-
  现金及现金等价物的净增加额48,561,778.67--26,383,843.83-
公告日期2025-08-082025-04-252025-04-252024-10-23
审计意见(境内)标准无保留意见
TOP↑